Why Choose Auburn Pharmaceutical?

  • No Contracts!
  • Hassle Free Return Policy
  • Great Savings on Short Date Items
  • Great Value on Close-out Items
  • Free Shipping (orders of $75 or more)
  • Over 3,000 AB Rated Generics
  • Fully Accredited
  • VAWD Accredited

Auburn Pharmaceutical has become one of the fastest growing generic distributors in the country. We proudly serve over 2,500 independent pharmacies, chains, hospitals and governmental agencies.

Auburn Pharmaceutical is a family-owned and operated business, established in 1993. The family has been involved in the generic pharmaceutical industry for over 45 years.

See why Auburn Pharmaceutical is "DIFFERENT" from the rest. Register and get started today!

"I have had superb experience with Auburn, especially with our rep, due to the company's general values, deals and personal ability"
Ryan from Wisconsin

"Auburn is very competitive with pricing as well as great customer service. The sales rep I have is personable and courteous"
Jay from Kentucky

"It has been a very positive, professional and enjoyable experience dealing with the company and particularly our rep, she's a delight"
Camille from Ohio

"Ordering through Auburn has always been an easy experience. The staff is friendly with no pressure to buy, but knowledgeable on specials and upcoming shortages."
Lorraine from Michigan

Study: Mondays may be 'mini New Year's' with regard to healthier behaviors

A new study in the American Journal of Preventive Medicine analyzing weekly patterns in health-related Google searches reveals a recurring pattern that could be leveraged to improve public health strategies.

read more

Friday April 18, 2014

Actavis, Forest Laboratories receive request for additional information from FTC

Actavis and Forest Laboratories on Thursday announced that they have each received a request for additional information from the Federal Trade Commission in connection with Actavis' pending acquisition of Forest.

read more

Friday April 18, 2014

Actavis to acquire five products from Akorn/Hi-Tech Pharmacal

Actavis on Friday announced that it has entered into agreements with Akorn and Hi-Tech Pharmacal to purchase four currently marketed products and one product under development for cash consideration.

read more

Friday April 18, 2014

FDA approves Merck's ragweed allergy remedy Ragwitek

Merck on Thursday announced that the Food and Drug Administration has approved Ragwitek (short ragweed pollen allergen extract) tablet for sublingual use (12 Amb a 1-U).

read more

Friday April 18, 2014